Trials / Completed
CompletedNCT00941681
Pharmacokinetics of Oral CK-1827452 in Patients With Stable Heart Failure
An Open Label Study to Investigate the Pharmacokinetics of CK-1827452 Administered Orally to Patients With Stable Heart Failure
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 35 (actual)
- Sponsor
- Cytokinetics · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is designed to understand the pharmacokinetics of different oral formulations of CK-1827452 being considered for future studies in patients with heart failure. This study will compare the pharmacokinetics and safety and tolerability of both modified-release (MR) and immediate-release (IR) oral formulations of CK-1827452.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | CK-1827452 | 50 mg MR CK-1827452 BID for 10 days |
| DRUG | CK-1827452 | 37.5 mg IR CK-1827452 TID for 10 days |
| DRUG | CK-1827452 | 100 mg MR CK-1827452 BID for 10 days |
Timeline
- Start date
- 2009-04-01
- Primary completion
- 2009-10-01
- Completion
- 2009-10-01
- First posted
- 2009-07-17
- Last updated
- 2013-02-12
- Results posted
- 2010-12-21
Locations
3 sites across 1 country: Georgia
Source: ClinicalTrials.gov record NCT00941681. Inclusion in this directory is not an endorsement.